APOB and chronic kidney disease: Patients with chronic kidney disease (CKD) may be more susceptible to some of the potential side effects of the diet, including metabolic acidosis and the unfavorable increase in low-density lipoprotein cholesterol (LDL-C) and apolipoprotein-B (apo-B).